Summer New! Clinical Books. Library Location. Hours & Contact. website:

Transcription

1 Summer 2018 Library Location The Junior Board Cancer Resource Library (JBCRL) is located off the lobby in the East Pavilion, Room 1106 of the Helen F. Graham Cancer Center & Research Institute (HFGCC&RI) located on the Christiana Hospital campus Hours & Contact Monday through Friday 8:30 a.m. 5:00 p.m website: New! Clinical Books AJCC Cancer Staging manual American Cancer Society s principle of oncology Cancer and exercise Clinical aromatherapy: essential oils in healthcare McWhinny s textbook of family medicine MD Anderson Surgical Oncology Handbook ONS Guide to breast care for oncology nurses ONS Your guide to cancer prevention A practical guide to cancer systems biology Tumors and cancer: head-neck-heart-lungs-gut The Washington manual of hematology and oncology Join the library with your picture ID to borrow books, DVDs, CDs, Creative kits and receive a free library card and tote bag.

2 SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 2 Body Mind Wellness Collection Mind Body Wellness Collection includes DVDs, CDs, and books on such topics as breathing well, relaxation, yoga, meditation, mindfulness, walking, and much more. New Kid movies An American Girl: Chrissa stands strong The best of Gumby The Cheetah Girls: 2 Disney Dogs 1 Ferninand Princess Diaries 2 The Star Molly: an American Girl: on the home front New Movies Babaziz the prince who contemplated his soul Boo: A Madea Halloween Daddy s home Diary of a mad black woman A dog s purpose Downsizing Forever my girl Game night Genius Ghost goes West Good deeds Greatest showman Jumanji: welcome to the jungle Just getting started Kingsman: the golden circle Madea s big happy family The whales of August Wonder Creative Journaling at Home Stop by the Library to participate in Creative Journaling at home. Participants can pick up prompts and start creative journaling. This activity was developed by Wendy Wallace, M.Ed., Healing Through Art teacher. Available to all. Visit Library for more details

3 SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 3 Consumer Health Books New Arrivals The adrenal thyroid revolution Anticancer living The breast cancer survival manual Breasts: the owner s manual Childhood leukemia: a guide for families PDR for nonprescription drugs Essential herbs & natural supplements The essential thyroid cookbook Everything happens for a reason Forks over knives: the cookbook Inkspirations for breast cancer survivors Male breast cancer: taking control Mayo clinic the integrative guide to good health Thinking through breast cancer: a philosophical exploration Writing as a way of healing Zumba: ditch the workout, join the party Writing as Healing Join us for a free two-hour workshop to explore expressive and reflective writing with Joan DelFattore, Ph.D., retired U of DE English professor. Each workshop is held the 2 nd Monday of each month (see dates below), 1:00 3:00 p.m. Explore a different topic each month with Joan. Call Materials are provided. Open to all interested adults Dates July 9, 2018 August 13, 2018 September 10, 2018 October 8, 2018 November 12, 2018 December 10, 2018 The NEW CRISPR Journal

4 SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 4 On Display at the Library Photography by Dianne Carnegie. These photographs are wildlife taken in the Galapagos and in her yard. She is a member of the Delaware Photographic Society. Expressive Art with Georgia Jones This program is ongoing and meets on the 2 nd & 4 th Friday of each month from 1-4 p.m. Come relax with art. Gentle instruction will be provided. Open to adults touched by cancer. Materials are provided. Registration required by calling New! In Print Journal Lancet Oncology Healing Through Art A free art class is offered by Wendy Wallace, M.Ed., art teacher. Open to adults touched by cancer. Check monthly activity calendar for dates. Materials are provided. Registration requested. (302) Look Good Feel Better is a free workshop offered by caring, volunteer beauty professionals. They teach women with cancer to manage the appearance side effects of treatment including instruction to address changes in skin, hair loss and nails, as well as tips on wardrobe/styling. To schedule your free workshop, call

5 SUMMER 2017 JUNIOR BOARD CANCER RESOURCE LIBRARY PAGE 5 A091304: A Phase I/Randomized Phase II Study of MLN0128 vs. Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma The objectives of the trial are: Primary Objective: --Primary Phase I objective To determine the safety and maximum tolerable dose of MLN0128 (TAK-228) within this patient population. Secondary Objective: --To evaluate adverse events. --To evaluate Overall Response Rate (ORR), Clinical Benefit Rate (CBR), and Duration of Response (DOR). --To evaluate Time to Progression (TTP) and Overall Survival (OS). Pre-Registration Eligibility Criteria (Step 0) --Central pathology review submission Registration Eligibility Criteria (Step 1) --Histologic Documentation and Measurable Disease --Prior Treatment Progression on at least one prior systemic chemotherapy for advanced, unresectable or metastatic disease. Prior adjuvant or neoadjuvant therapy is not included as prior systemic chemotherapy unless treatment occurred within the 6 months prior to study enrollment. There is no limit to the number of prior lines of treatment a patient has received. No treatment with biological therapy, immunotherapy, chemotherapy, investigational agent for malignancy, or radiation 28 days before study registration. No treatment with nitrosourea or mitomycin 42 days before study registration. No treatment with radiation therapy 28 days before study registration. Patients should have resolution of any toxic effects of prior therapy (except alopecia) to NCI CTCAE, Version 4.0, grade 1 or less. Prior treatment with pazopanib or any PI3K, mtor, AKT, or dual PI3K/mTOR complex (TORC1/TORC2) inhibitors will be prohibited. -- Age 18, ECOG performance status 1, and Not pregnant and not nursing --Parameter use for chronic concomitant treatment with proton pump inhibitors, treatment with strong inhibitors of CYP3A4 inhibitors, or chronic concomitant treatment with strong CYP3A4 inducers. --Required Initial Laboratory Values Treatment: PHASE I ARM 1: TAK mg weekly till progression ARM 2: Pazopanib 800mg PO once daily (If progression occurs, may cross over to Arm 1) For information regarding this clinical trial or if you would like to have the list of open protocols ed to you, please call the Cancer Research Office at (302) or akee@christianacare.org.